Screening for Diabetic Cardiomyopathy (DCM) Therapies in Induced Pluripotent Stem (iPS) Cell–derived Cardiomyocytes

Science-Business eXchange
doi 10.1038/scibx.2014.1360
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy